Crohn's Disease

AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
Endpoints
Mon, 10/3/16 - 10:09 am
AstraZeneca
Amgen
Allergan
MEDI2070
ulcerative colitis
Crohn's Disease
Will Gilead (GILD) Stock Be Helped by Positive Crohn's Drug Results?
TheStreet.com
Mon, 09/26/16 - 03:25 pm
Gilead Sciences
Crohn's Disease
filgotinib
Galapagos
Celgene’s update on its big Crohn’s drug? Trust us, we’re doing fine
Endpoints
Mon, 09/12/16 - 09:27 am
Celgene
Crohn's Disease
GED-0301
How AbbVie Expects Risankizumab to Be a Transformative Therapy
Market Realist
Wed, 08/24/16 - 10:40 am
AbbVie
risankizumab
Crohn's Disease
Next Up for Celgene's Crohn's Pill: A Snapshot Inside Patients' Colons
TheStreet.com
Fri, 07/15/16 - 10:41 am
Celgene
Crohn's Disease
GED-0301
Otezla
ozanimod
AbbVie’s Newly Licensed Drug Scores Against Crohn’s Disease
Investors.com
Tue, 05/24/16 - 11:54 pm
AbbVie
Crohn's Disease
risankizumab
Boehringer Ingelheim
J&J psoriasis drug Stelara tames Crohn's disease in second trial
Yahoo/Reuters
Fri, 03/18/16 - 10:41 am
JNJ
psoriasis
Stelara
Crohn's Disease
Galapagos' inflammation drug comes through in Crohn's with Phase III in sight
Fierce Biotech
Tue, 12/8/15 - 10:54 pm
Galapagos
Crohn's Disease
filgotinib
AstraZeneca Sells Drug Rights To Perrigo
Bidness, ETC
Mon, 11/23/15 - 09:33 am
AstraZeneca
Perrigo Company
Entocort
Crohn's Disease
J&J's Stelara succeeds in Phase III Crohn's disease trial
Yahoo/Reuters
Mon, 10/19/15 - 09:56 am
JNJ
Stelara
Crohn's Disease
clinical trials
Does Celgene Have Another Blockbuster on the Way?
Investopedia
Thu, 03/26/15 - 09:45 pm
Celgene
GED-0301
autoimmune disease
Crohn's Disease
Celgene's Crohn's Disease Drug Candidate Highlighted in NEJM
TheStreet.com
Thu, 03/19/15 - 08:07 am
Celgene
Crohn's Disease
Mongersen
New England Journal of Medicine
FDA postpones key hearing on biosimilar copy of blockbuster drug
Yahoo/Reuters
Thu, 02/26/15 - 09:55 am
FDA
biosimilars
Rensima
Remicade
JNJ
rheumatoid arthritis
Crohn's Disease
Hospira
Celltrion
Celgene Crohn's drug trial successful
Yahoo/Investors Business Daily
Tue, 10/21/14 - 08:02 am
Celgene
Crohn's Disease
Mongersen
First Detailed Look at Celgene Crohn's Disease Pill Impresses
TheStreet.com
Mon, 10/20/14 - 10:55 am
Celgene
Crohn's Disease
GED-0301
Was Celgene's Crohn's Disease Drug Worth The Price?
Investors.com
Thu, 10/16/14 - 07:48 am
Celgene
Crohn's Disease
GED-0301
Safety Worries Over Celgene's Experimental Crohn's Drug Overblown
TheStreet.com
Wed, 09/17/14 - 08:41 am
Celgene
Crohn's Disease
GED-301
New biotherapeutics drug for Crohn's to enter trials
Pharmaphorum
Wed, 09/3/14 - 08:17 am
Crohn's Disease
IBS
Blautix
Thetanix
4D Pharma
Takeda’s Bowel Disease Drug Approved by U.S. Regulators
Bloomberg
Wed, 05/21/14 - 10:26 am
Takeda
FDA
Entyvio
vedolizumab
ulcerative colitis
Crohn's Disease
Celgene enters deal potentially worth over $2.5 billion for Nogra Pharma's Crohn's disease drug
First Word Pharma
Thu, 04/24/14 - 11:36 am
Celgene
Nogra Pharma
Crohn's Disease
GED-0301

Pages